Tolerance and Pharmacokinetic Interactions of Rifabutin and Clarithromycin in Human Immunodeficiency Virus-Infected Volunteers
This study evaluated the tolerance and potential pharmacokinetic interactions between clarithromycin (500 mg every 12 h) and rifabutin (300 mg daily) in clinically stable human immunodeficiency virus-infected volunteers with CD4 counts of <200 cells/mm(3). Thirty-four subjects were randomized equall...
Na minha lista:
| Udgivet i: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Microbiology (ASM)
1998
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105510/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9517944/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.3.631 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
